ARCHIVES

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985

Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years

May 9, 1997

National Policy: IOM Seeks Nominations for Cancer Policy Board

November 29, 1996

Judah Folkman, Angiogenesis Pioneer, Dead at 74.

January 18, 2008

DCPC Advisors Commit $32 Mil. To Chemoprevention

June 7, 1991